Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.88
-0.10 (-0.86%)
Apr 23, 2026, 2:09 PM EDT - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $218.5 million as of April 23, 2026. Its market cap has increased by 157.92% in one year.
Market Cap
218.50M
Enterprise Value
218.54M
1-Year Change
157.92%
Ranking
Category
Stock Price
$11.88
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $218.50M, a decrease of -30.02%. That is a compound annual growth rate of -11.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 220.38M | 58.43% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 228.06M |
| Keros Therapeutics | 225.57M |
| Achieve Life Sciences | 225.21M |
| Codexis | 224.45M |
| ALX Oncology Holdings | 223.73M |
| Context Therapeutics | 221.43M |
| Nkarta | 220.29M |
| MediWound | 219.52M |